Thenappan Chandrasekar

14PUBLICATIONS
39CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersPharmacogenomicsVocational education and training curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 02, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

|Nov 20, 2024
Metastasis development in non-muscle-invasive bladder cancer.

Michael Leyderman, Thenappan Chandrasekar, Petros Grivas

|Apr 23, 2024
Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer.

Rishabh K Simhal, Kerith R Wang, Yash B Shah

|Apr 13, 2023
Feasibility, acceptability, and behavioral outcomes of a multimodal intervention for prostate cancer patients: Experience from the MARTINI lifestyle program.

Imke Thederan, Aliaksandra Pott, Alexander Krueger

|Nov 09, 2021
Association of Race With Cancer-Related Financial Toxicity.

John Panzone, Christopher Welch, Alicia Morgans

|Sep 14, 2020
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?

Hanan Goldberg, Rachel Glicksman, Dixon Woon

Pageof 3

Frequent Collaborators

8 joint publications

Hanan Goldberg

5 joint publications

Zachary Klaassen

4 joint publications

Christopher J D Wallis

2 joint publications

Derya Tilki